Anti-NAT1 抗体 [EPR3221(2)] - BSA and Azide free
Anti-NAT1 antibody [EPR3221(2)] - BSA and Azide free
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal NAT1 antibody. Carrier free. Suitable for ICC/IF, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 1 publication.
別名を表示する
AAC1, NAT1, Arylamine N-acetyltransferase 1, Arylamide acetylase 1, Monomorphic arylamine N-acetyltransferase, N-acetyltransferase type 1, MNAT, NAT-1
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-NAT1 antibody [EPR3221(2)] - BSA and Azide free (AB247765)
This data was developed using ab109114, the same antibody clone in a different buffer formulation.
Flow Cytometry analysis of LNCaP (Human prostate carcinoma epithelial cell) cells labeling NAT1 with purified ab109114 at 1/100 dilution (10 μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- WB
Unknown
Western blot - Anti-NAT1 antibody [EPR3221(2)] - BSA and Azide free (AB247765)
This data was developed using ab109114, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-NAT1 antibody [EPR3221(2)] (<a href='/products/primary-antibodies/nat1-antibody-epr32212-ab109114'>ab109114</a>) at 1/1000 dilution
Lane 1:
U937 cell lysate at 10 µg
Lane 2:
Fetal liver cell lysate at 10 µg
Lane 3:
LnCaP cell lysate at 10 µg
Lane 4:
Human bladder cell lysate at 10 µg
Lane 5:
HT-1376 cell lysate at 10 µg
Predicted band size: 34 kDa
false
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-NAT1 antibody [EPR3221(2)]
Reactivity data
製品の詳細
ab247765 is the carrier-free version of ab109114.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NAT1 plays a significant role in detoxifying environmental toxins and carcinogens. The enzyme's activity contributes to the acetylation a phase II metabolic reaction which often converts lipophilic substrates into more hydrophilic products for excretion. NAT1 stands independently and does not form part of a larger complex. It shares functional similarities with other N-acetyltransferases but its substrate specificity can differ which influences its distinct biological role.
Pathways
NAT1 is intricately involved in metabolic and detoxification pathways. It participates in the biotransformation of various drugs and environmental carcinogens making it important for xenobiotic metabolism. NAT1 often interacts with cytochrome P450 enzymes during these processes which also contribute to the initial phase I oxidation reactions. The interplay between NAT1 and these detoxification pathways highlights the enzyme's contribution to reducing potential toxicities.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (1)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 26:409 PubMed37600337
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com